You have 9 free searches left this month | for more free features.

City

Lyon Cedex (1)

Condition

Gastroesophageal Adenocarcinoma (2)

Glioblastoma Multiforme (2)

Pancreatic Ductal Adenocarcinoma (2)

Brain Neoplasms (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

68ga-ff58 (2)

177lu-ff58 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

68ga-ff58

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

Not yet recruiting

Pancreatic Ductal Adenocarcinoma
+2 more

68Ga-FF58
177Lu-FF58

(no location specified)

Jul 28, 2023

Glioblastoma Multiforme, Brain Tumors, Gastroesophageal Adenocarcinoma Trial in Lyon Cedex (68Ga-FF58)

Recruiting

Glioblastoma Multiforme
+3 more

68Ga-FF58

Lyon Cedex, France

Novartis Investigative Site

Aug 9, 2022